EH-APP(1-22)-Melittin (21-26)

General Information


DRACP ID  DRACP01079

Peptide Name   EH-APP(1-22)-Melittin (21-26)

Sequence  GEILCNLCTGLINTLENLLTTKRKRQQ

Sequence Length  27

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
U-937 Adult acute monocytic leukemi; Acute monoblastic/monocytic leukemia Leukemia LC=50 µM Trypan blue assay 1h 1
Jurkat Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia Leukemia LC50=8 µM Trypan blue assay 1h 1

Hemolytic Activity  Human erythrocytes: 50% Hemolysis=10 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01079

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C130H230N40O41S2

Absent amino acids  ADFHMPSVWY

Common amino acids  L

Mass  353758

Pl  8.82

Basic residues  4

Acidic residues  2

Hydrophobic residues  8

Net charge  2

Boman Index  -5204

Hydrophobicity  -30

Aliphatic Index  115.56

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  125

Absorbance 280nm  4.81

Polar residues  11

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 8146160

Title  Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica

Doi 10.1073/pnas.91.7.2602

Year  1994

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.